Access to anti-retroviral drugs, male in Serbia
Serbia: Access to anti-retroviral drugs, male was 65.0% in 2024. ▲ Rising
Access to anti-retroviral drugs, male in Serbia, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
In 2024, access to anti-retroviral drugs, male in Serbia stood at 65.0%. That is the highest value across all 25 years on record.
That represents a change of up 1.6% on the previous year and up 41.3% over ten years.
Over the whole period, access to anti-retroviral drugs, male in Serbia peaked at 65.0% in 2024 and was at its lowest, 0.0%, in 2000.
Serbia ranks 83rd of 141 countries on this measure, in the middle of the range.
The long-run direction has been consistently rising across the 25 years of available data.
Access to anti-retroviral drugs, male in Serbia, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 30.0% | — |
| 2004 | 37.0% | +23.3% |
| 2005 | 43.0% | +16.2% |
| 2006 | 42.0% | -2.3% |
| 2007 | 42.0% | +0.0% |
| 2008 | 42.0% | +0.0% |
| 2009 | 42.0% | +0.0% |
| 2010 | 43.0% | +2.4% |
| 2011 | 44.0% | +2.3% |
| 2012 | 44.0% | +0.0% |
| 2013 | 45.0% | +2.3% |
| 2014 | 46.0% | +2.2% |
| 2015 | 48.0% | +4.3% |
| 2016 | 50.0% | +4.2% |
| 2017 | 53.0% | +6.0% |
| 2018 | 60.0% | +13.2% |
| 2019 | 60.0% | +0.0% |
| 2020 | 60.0% | +0.0% |
| 2021 | 62.0% | +3.3% |
| 2022 | 63.0% | +1.6% |
| 2023 | 64.0% | +1.6% |
| 2024 | 65.0% | +1.6% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 27.8% | 0.0% | 43.0% | 10 |
| 2010s | 49.3% | 43.0% | 60.0% | 10 |
| 2020s | 62.8% | 60.0% | 65.0% | 5 |
Countries ranked near Serbia
More gender data for Serbia
- Child population (UN estimates and projections) 899.28 (2030)
- Child population (UN estimates and projections) (0-14), annual growth -1.33 % change on previous year (2030)
- Population 5,562 (2030)
- Working-age population (UN estimates and projections) 5,562 (2030)
- Population (UN estimates and projections), annual growth rate -0.6031 % change on previous year (2030)
- Age population, age 00, female, interpolated 28,084 (2025)
- Age population, age 00, male, interpolated 30,023 (2025)
- Age population, age 01, female, interpolated 28,439 (2025)
- Age population, age 01, male, interpolated 30,406 (2025)
- Age population, age 02, female, interpolated 29,091 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, male in Serbia?
- Access to anti-retroviral drugs, male in Serbia was 65.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, male recorded in Serbia?
- The highest recorded value was 65.0% in 2024.
- What is the lowest access to anti-retroviral drugs, male recorded in Serbia?
- The lowest recorded value was 0.0% in 2000.
- How does Serbia rank for access to anti-retroviral drugs, male?
- Serbia ranks 83rd out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, male rising or falling in Serbia?
- Over the last ten years it is up 41.3%. The long-run trend across the full record is rising.
- Where does this Serbia data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, male (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.